Dr. Amanda Hays

Scientific Officer and Senior Director
BioAgilytix

Amanda Hays is a Scientific Officer and Senior Director at BioAgilytix Laboratories. She offers more than a decade of lab experience in multiple fields, including pharmacology, drug metabolism, immunoassays, immunogenicity, biomarkers, flow cytometry and qPCR and has supported programs through all stages in drug development. In her current role, she provides global scientific leadership and technical guidance at BioAgilytix. Dr. Hays is the Chair of the AAPS Biomarkers and Precision Medicine community and the AAPS qPCR working group, among other volunteer leadership positions. She earned her Ph.D. in Pharmacology from the University of Kansas Medical Center in Kansas City, KS.

Securing Cell Therapy Success: The Role of PCR in Quality Control

In this webinar, our expert speakers will explore the vital role of qPCR and digital PCR in supporting advanced therapy medicinal products, including cell therapies. Discover best practices for assay design, validation parameters and acceptance criteria crucial for ensuring the safety and efficacy of cell therapy programs. Learn how molecular precision can safeguard these innovative therapies and drive breakthroughs in the field.